A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway

Update your browser to view ScienceDirect.

Request details:

Request ID: 8e74c6140cff15ed-LAX
IP: 47.97.18.252
UTC time: 2024-11-23T23:00:09+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4